Kamal Khorfan, MD
Gastroenterology · Owosso, MINPI 1174055958
Payments from drug & device makers
Across 68 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$267
- AbbVie$250
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$189
- Johnson & Johnson$151
- QOL Medical, LLC$86
- Intercept Pharmaceuticals, Inc.$81
- plus $321 from 9 others
What the payments were for
- Food & beverage$1,345100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $267 |
| AbbVie | 12 | $250 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $189 |
| Johnson & Johnson | 7 | $151 |
| QOL Medical, LLC | 4 | $86 |
| Intercept Pharmaceuticals, Inc. | 5 | $81 |
| Pfizer | 4 | $80 |
| Gilead | 3 | $47 |
| Lilly USA, LLC | 2 | $42 |
| Ardelyx, Inc. | 2 | $38 |
| Madrigal Pharmaceuticals | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Bristol Myers Squibb | 1 | $17 |
| Novo Nordisk | 1 | $14 |
How this compares
$1,345 in reported general payments places this provider in the 40th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 61 | $1,743 |
| Pantoprazole Sodium | 23 | $437 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $409 |
| Omeprazole | 24 | $146 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Owosso
- Allan CoatesWyoming$5.9M
- Ronald FogelChesterfield$5.1M
- Stuart GordonDetroit$4.3M
- Jeffery BerinsteinAnn Arbor$3.3M
- Najm SoofiYpsilanti$2.6M
- Peter HigginsAnn Arbor$2.4M
- Partha NandiTroy$1.4M
- Frederick AskariAnn Arbor$1.4M
- Reena SalgiaDetroit$1.3M
- Kimberly BrownDetroit$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.